Covered recipient · General Payments record
KASHMIR KAUR RAI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,980.05
- Reported across 177 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $604.47 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $175.43 | 4 |
| ABBVIE INC. | $132.94 | 6 |
| AIMMUNE THERAPEUTICS, INC. | $131.22 | 6 |
| IBSA Pharma Inc. | $104.71 | 6 |
| UCB, Inc. | $29.72 | 1 |
| Acella Pharmaceuticals, LLC | $15.40 | 1 |
| Novo Nordisk AS | $15.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.02 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353597 | CMS |
| ABBVIE INC. | $4.95 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353601 | CMS |
| ABBVIE INC. | $32.61 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353605 | CMS |
| ABBVIE INC. | $9.55 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353609 | CMS |
| ABBVIE INC. | $30.63 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353613 | CMS |
| ABBVIE INC. | $29.18 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353617 | CMS |
| Acella Pharmaceuticals, LLC | $15.40 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126635928 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.09 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147016585 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.20 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146961980 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $25.77 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146963639 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $22.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146971083 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $21.48 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000659 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.75 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147000759 | CMS |
| IBSA Pharma Inc. | $18.55 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984558 | CMS |
| IBSA Pharma Inc. | $18.30 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984560 | CMS |
| IBSA Pharma Inc. | $18.53 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142972837 | CMS |
| IBSA Pharma Inc. | $19.79 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974073 | CMS |
| IBSA Pharma Inc. | $13.34 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975082 | CMS |
| IBSA Pharma Inc. | $16.20 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975769 | CMS |
| Lilly USA, LLC | $14.84 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135097980 | CMS |
| Lilly USA, LLC | $124.99 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099302 | CMS |
| Lilly USA, LLC | $19.37 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121889 | CMS |
| Lilly USA, LLC | $16.23 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076431 | CMS |
| Novo Nordisk Inc | $15.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097816411 | CMS |
| UCB, Inc. | $29.72 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143507453 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.